Investors bought shares of Humana Inc (NYSE:HUM) on weakness during trading hours on Thursday. $75.01 million flowed into the stock on the tick-up and $52.87 million flowed out of the stock on the tick-down, for a money net flow of $22.14 million into the stock. Of all companies tracked, Humana had the 33rd highest net in-flow for the day. Humana traded down ($1.23) for the day and closed at $275.02
HUM has been the subject of several recent analyst reports. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $377.00 price objective for the company in a report on Thursday, October 4th. JPMorgan Chase & Co. raised shares of Humana from a “neutral” rating to an “overweight” rating and set a $283.00 price objective for the company in a report on Thursday, December 20th. Royal Bank of Canada raised their price objective on shares of Humana from $318.00 to $349.00 and gave the stock a “sector perform” rating in a report on Thursday, November 8th. SunTrust Banks raised their price objective on shares of Humana to $380.00 and gave the stock a “hold” rating in a report on Wednesday, September 19th. Finally, BMO Capital Markets set a $390.00 price objective on shares of Humana and gave the stock a “buy” rating in a report on Thursday, November 8th. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $349.53.
The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.68 and a current ratio of 1.68. The firm has a market cap of $37.90 billion, a price-to-earnings ratio of 24.21, a P/E/G ratio of 1.08 and a beta of 1.09.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 25th. Investors of record on Monday, December 31st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend is Friday, December 28th. Humana’s dividend payout ratio is currently 8.54%.
In related news, insider Roy A. Beveridge sold 4,622 shares of the firm’s stock in a transaction that occurred on Thursday, November 8th. The shares were sold at an average price of $341.06, for a total value of $1,576,379.32. Following the completion of the sale, the insider now owns 10,621 shares of the company’s stock, valued at $3,622,398.26. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director David A. Jr/Ky Jones sold 600 shares of the firm’s stock in a transaction that occurred on Saturday, November 16th. The shares were sold at an average price of $88.05, for a total transaction of $52,830.00. The disclosure for this sale can be found here. In the last three months, insiders sold 9,078 shares of company stock valued at $2,570,350. 0.60% of the stock is currently owned by company insiders.
Several institutional investors have recently modified their holdings of HUM. FMR LLC grew its holdings in Humana by 1.4% during the 3rd quarter. FMR LLC now owns 12,379,797 shares of the insurance provider’s stock worth $4,190,809,000 after acquiring an additional 167,283 shares during the period. BlackRock Inc. grew its holdings in Humana by 1.2% during the 3rd quarter. BlackRock Inc. now owns 12,311,736 shares of the insurance provider’s stock worth $4,167,767,000 after acquiring an additional 140,731 shares during the period. Vanguard Group Inc grew its holdings in Humana by 1.4% during the 3rd quarter. Vanguard Group Inc now owns 10,104,225 shares of the insurance provider’s stock worth $3,420,482,000 after acquiring an additional 140,864 shares during the period. Capital International Investors boosted its position in shares of Humana by 3,030.3% during the third quarter. Capital International Investors now owns 8,217,296 shares of the insurance provider’s stock worth $2,781,719,000 after purchasing an additional 7,954,786 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Humana by 14.1% during the third quarter. Renaissance Technologies LLC now owns 3,174,800 shares of the insurance provider’s stock worth $1,074,733,000 after purchasing an additional 391,300 shares in the last quarter. 92.69% of the stock is owned by institutional investors and hedge funds.
About Humana (NYSE:HUM)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Featured Story: Are 12b-1 Fees Affecting Your Mutual Fund Performance?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.